Navigation Links
Javelin Pharmaceuticals Announces Successful Pivotal Phase 3 Trial,Data

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Jun 19, 2007 - Javelin Pharmaceuticals (AMEX: JAV) announced today that its product candidate Rylomine(TM) (intranasal morphine) successfully met its primary clinical endpoint, the Sum of the Pain Intensity Difference (SPID) scores over 0-24 hours postoperatively. In this first of two pivotal Phase 3 studies, patients with moderate-to-severe pain after elective orthopedic surgery were given 7.5 mg Rylomine every hour as needed, 15 mg Rylomine every 3 hours as needed, or 7.5 mg intravenous (IV) morphine every 3 hours as needed. Patients in each of the three active treatment groups had significantly better (p less than .01 or less) SPID scores over 24 hours than the corresponding placebo groups.

"Parenteral morphine is the gold standard for postoperative analgesia," commented Dr. Daniel B. Carr, CEO and CMO of Javelin Pharmaceuticals. "Today's gratifying results extend our prior positive study findings showing that Rylomine is a simple, effective alternative to more complex, cumbersome and costly methods of postoperative opioid analgesia. We look forward to continuing the development of this innovative product candidate."

There were no serious adverse events related to the study drug. Local adverse events associated with nasal administration (bad taste, throat irritation, instillation site reaction, nasal erythema, nasal irritation) were more common with Rylomine or intranasal placebo than the intravenous morphine groups. General systemic adverse events related to active drug were similar across morphine treatment groups regardless of route of administration and consistent with morphine's known pharmacologic effects (dizziness, nausea, transient decreased oxygen saturation, and vomiting).

Full analyses of the data are ongoing and will be reported when available.

About the Study

This study, termed MOR-003, involved 278 randomized patients with moderate
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Javelin Pharmaceuticals Phase II Rylomine (Intranasal Morphine) Data Published in Pain Medicine
2. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
3. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
5. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
6. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
7. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
8. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
9. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
10. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
11. Cyclacel Pharmaceuticals Announces Results of Phase II Seliciclib Combination Studies
Post Your Comments:
(Date:12/24/2014)... 24, 2014  Conkwest, Inc., the Natural Killer ... Natural Killer (NK) cell-line platform, Neukoplast® (NK-92™) as ... Soon-Shiong , NantWorks founder, physician scientist and biotechnology ... purchase approximately $48 million of the Company,s Class ... he will be named Co-Chairman of the Conkwest ...
(Date:12/24/2014)... and LONDON , December 24, 2014 ... are expected to grow at an average rate of ... value and volume. Hip, knee and spine surgeries are ... in emerging economies they have a lower penetration. Increased ... the use of composites. Non-metallic orthopedic devices have gained ...
(Date:12/24/2014)... , Dec. 23, 2014  Advanced Medical ... company engaged primarily in the development of brachytherapy ... applications, today announced that it has filed a ... and Drug Administration ("FDA") for marketing clearance for ... 513(f)(2) of the U.S. Food, Drug and Cosmetic ...
Breaking Medicine Technology:Conkwest Announces $50m In Strategic Investments And Appoints NantWorks Founder, Dr. Patrick Soon-Shiong As Co-Chairman Of The Board 2Conkwest Announces $50m In Strategic Investments And Appoints NantWorks Founder, Dr. Patrick Soon-Shiong As Co-Chairman Of The Board 3Conkwest Announces $50m In Strategic Investments And Appoints NantWorks Founder, Dr. Patrick Soon-Shiong As Co-Chairman Of The Board 4Conkwest Announces $50m In Strategic Investments And Appoints NantWorks Founder, Dr. Patrick Soon-Shiong As Co-Chairman Of The Board 5Use of Composites in Orthopedic Industry to Reach $596 Million by 2020 2Use of Composites in Orthopedic Industry to Reach $596 Million by 2020 3Advanced Medical Isotope Corporation Files a "de novo" Submission for Y-90 RadioGel(TM) Device 2Advanced Medical Isotope Corporation Files a "de novo" Submission for Y-90 RadioGel(TM) Device 3
... Obama administration embarks on improving the efficiency of government ... Medicare & Medicaid Services, (CMS) supervision of the Medicare ... pressed to find a government operation more outdated, mismanaged ... fact, recent audits by the government,s own contractors demonstrate ...
... Pa., Feb. 10, 2011 Kensey Nash Corporation (Nasdaq: ... the Canaccord Genuity Musculoskeletal Conference held on Tuesday, February ... Douglas G. Evans, Kensey Nash,s Chief Operating ... 3:00 p.m. (PT).  The presentation materials will be available ...
Cached Medicine Technology:Mobility Matters: Frustrated Mobility Providers Ask White House to Address Gross Mismanagement of Mobility Benefit 2Mobility Matters: Frustrated Mobility Providers Ask White House to Address Gross Mismanagement of Mobility Benefit 3Mobility Matters: Frustrated Mobility Providers Ask White House to Address Gross Mismanagement of Mobility Benefit 4Mobility Matters: Frustrated Mobility Providers Ask White House to Address Gross Mismanagement of Mobility Benefit 5
(Date:12/24/2014)... -- Researchers say they have used human embryonic stem ... sperm. While this had already been done using ... these types of cells -- called primordial germ cells ... according to the team at the University of Cambridge ... is one of the earliest events during early mammalian ...
(Date:12/24/2014)... Angeles, CA (PRWEB) December 24, 2014 ... wreak havoc on those who have an intolerance to ... to diarrhea, gas, bloating, migraine headaches, joint pain and ... gluten free diet plans that deliver safe and ... certain foods that trigger a gluten allergy reaction. These ...
(Date:12/24/2014)... (PRWEB) December 24, 2014 The ... is a professional and in-depth research report on ... introduces COC basic information, including its definition, classification, ... news analysis, etc. This report also presents product ... Production is separated by regions, technology and applications. ...
(Date:12/24/2014)... For nearly 20 years, June Cotner has ... and all of life's rites of passage. Here, she ... Ling, in Toasts: The Perfect Words to Celebrate ... Organized by category and containing many original toasts written ... this timely tome contains sayings famous and profound, suitable ...
(Date:12/24/2014)... (PRWEB) December 24, 2014 As 2014 ... reminds homeowners that before investing time and money into ... a licensed professional that specializes in tankless and eco-friendly ... to replace their water heater in 2015 to research ... decision. , Greenstar Home Services specializes in ...
Breaking Medicine News(10 mins):Health News:Diet Doc Adds Gluten Free Diet Plans to Their Stable of Specialized Weight Loss Programs 2Health News:Diet Doc Adds Gluten Free Diet Plans to Their Stable of Specialized Weight Loss Programs 3Health News:COC/ Cyclic Olefin Copolymer Market: Global 2015-2020 Forecasts & Research Report Now at DeepResearchReports.com 2Health News:COC/ Cyclic Olefin Copolymer Market: Global 2015-2020 Forecasts & Research Report Now at DeepResearchReports.com 3Health News:Greenstar Home Services Offers Tankless Water Heater Advice to Local Homeowners 2
... Distinctively Blue Award for Hospital Quality,Improvement, ... hospital-acquired infections in the mid-Atlantic region were,recently ... BlueCross BlueShield,Association of America. CareFirst BlueCross BlueShield ... Innovations for the 100,000 Lives and,Beyond Collaborative. ...
... Florida,s hospitals and the,Coalition to Protect Florida,s ... today to restore no-fault auto insurance, calling it ... in auto,accidents. Governor Crist,s signing into law ... and mandatory Personal Injury Protection (PIP),coverage, will be ...
... investigating claims that pain pumps used in the shoulder ... joint may cause life-long pain and suffering, ... surgeon this week issued a warning that a,commonly used device ... in the shoulder joint space. The devices, manufactured,by Stryker Corporation ...
... say , THURSDAY, Oct. 11 (HealthDay News) -- A ... be linked to a pathway that clears cholesterol from ... , They said their finding could help lead ... of cholesterol-related diseases such as atherosclerosis (clogged arteries) and ...
... 11 Collaborative Drug Discovery,Inc. (CDD, Inc.) and ... a project aimed at speeding the development of ... The collaboration combines the malaria drug data and ... of the St. Jude,Department of Chemical Biology and ...
... Properties, Inc. (NYSE: NHP ) announced today that ... November 6, 2007 after the,close of trading on the ... call on Wednesday, November 7, 2007 at 8:30 a.m. ... the Company,s financial,performance and operating results for the third ...
Cached Medicine News:Health News:National Award Recognizes Delmarva Foundation and CareFirst BlueCross BlueShield Quality Improvement Efforts 2Health News:Hospital Coalition Says Governor's No-Fault Bill Signing Provides a 'Great Protection' for Florida Consumers 2Health News:Study Author Urges Peers to Stop Using Pain Pumps in the Shoulder Joint as Seasonal Surge in Use Approaches 2Health News:Study Author Urges Peers to Stop Using Pain Pumps in the Shoulder Joint as Seasonal Surge in Use Approaches 3Health News:Long-Life Gene Might Help Lower Cholesterol 2Health News:Collaborative Drug Discovery, Inc. and St. Jude Children's Research Hospital Make Malaria Research Data Available to Speed Drug Development 2Health News:Collaborative Drug Discovery, Inc. and St. Jude Children's Research Hospital Make Malaria Research Data Available to Speed Drug Development 3Health News:NHP Announces Third Quarter Earnings Release Date and Conference Call/Webcast 2Health News:NHP Announces Third Quarter Earnings Release Date and Conference Call/Webcast 3
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: